SIA
AVNS icon

Stancorp Investment Advisers’s Avanos Medical AVNS Stock Holding History

Stancorp Investment Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$6K Buy
128
+58
+83% +$2.69K ﹤0.01% 508
2014
Q4 		$3K Buy
+70
New +$2.75K ﹤0.01% 574

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Stancorp Investment Advisers's AVNS Position: Q1 2015 in Review

Stancorp Investment Advisers increased its Avanos Medical (AVNS) stake by 83% in Q1 2015, buying an estimated $2.69K and bringing the position to 128 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

Stancorp Investment Advisers first reported a position in AVNS in Q4 2014 and has held it in 2 quarters since. 447 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

  • Stancorp Investment Advisers held 128 shares of Avanos Medical worth $6K as of Q1 2015.
  • Stancorp Investment Advisers bought 58 Avanos Medical shares in Q1 2015, an estimated $2.69K.
  • Avanos Medical made up ﹤0.01% of Stancorp Investment Advisers's portfolio in Q1 2015, its #508 holding.
  • Stancorp Investment Advisers first reported a position in Avanos Medical in Q4 2014 and has held it in 2 quarters since.
  • 447 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.